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ABSTRACT
Clear cell renal cell carcinoma (ccRCC) has a poor prognosis despite novel 
biological targeted therapies. Tumor aggressiveness and poor survival may correlate 
with tumor grade at diagnosis and with complex metabolic alterations, also involving 
glucose and lipid metabolism. However, currently no grade-specific metabolic therapy 
addresses these alterations. Here we used primary cell cultures from ccRCC of low- and 
high-grade to investigate the effect on energy state and reduced pyridine nucleotide 
level, and on viability and proliferation, of specific inhibition of glycolysis with 
2-deoxy-D-glucose (2DG), or fatty acid oxidation with Etomoxir. Our primary cultures 
retained the tissue grade-dependent modulation of lipid and glycogen storage and 
aerobic glycolysis (Warburg effect). 2DG affected lactate production, energy state and 
reduced pyridine nucleotide level in high-grade ccRCC cultures, but the energy state 
only in low-grade. Rather, Etomoxir affected energy state in high-grade and reduced 
pyridine nucleotide level in low-grade cultures. Energy state and reduced pyridine 
nucleotide level were evaluated by ATP and reduced 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium (MTT) dye quantification, respectively. 2DG treatment impaired 
cell proliferation and viability of low-grade ccRCC and normal cortex cultures, whereas 
Etomoxir showed a cytostatic and cytotoxic effect only in high-grade ccRCC cultures. 
Our data indicate that in ccRCC the Warburg effect is a grade-dependent feature, 
and fatty acid oxidation can be activated for different grade-dependent metabolic 
needs. A possible grade-dependent metabolic therapeutic approach in ccRCC is also 
highlighted.
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INTRODUCTION
Clear cell renal cell carcinoma (ccRCC) is the 
most common (70–80%) and lethal subtype of renal cell 
carcinomas and accounts for 90% of all kidney cancers 
[1]. Although biological and targeted therapies have 
shown promising results for advanced ccRCC [2–3] its 
prognosis remains poor, with a median overall survival of 
21.4 months [4]. In ccRCC the tumor grade at diagnosis 
may affect survival with a 5-year cancer specific mortality 
rate ranging from about 7% for grade I to about 58% for 
grade IV cases [5].
The most striking morphological feature of ccRCC 
cells is their clear cytoplasm due to lipid and glycogen 
accumulation [6], suggesting possible involvement of 
their metabolism in ccRCC progression. Transcriptomic, 
proteomic and metabolomic profiling of ccRCC 
tissues support this involvement revealing metabolic 
reprogramming characterized by up-regulation of aerobic 
glycolysis (Warburg effect), the pentose phosphate pathway, 
fatty acid synthesis, glutamine and glutathione metabolism, 
and by down-regulation of the tricarboxylic acid (TCA) 
cycle, fatty acid β oxidation (FAO), and oxidative 
phosphorylation [7–10]. More recently, by using different 
omics approaches, several groups revealed that specific 
metabolic alterations, in particular the down-regulation 
of TCA cycle and the up-regulation of pentose phosphate 
pathway and fatty acid synthesis, may correlate with tumor 
aggressiveness and poor survival in ccRCC patients [11, 7]. 
Hakimi et al. investigated the association between metabolic 
shifts and ccRCC clinical stages, revealing an increase 
of fatty acid biosynthesis and a decrease of oxidative 
phosphorylation in early-stage tumors, whereas these 
metabolic patterns reversed and glutathione metabolism 
increased in late-stage tumors [8]. A decrease of specific 
FAO enzyme expression has also been found to correlate 
with an increase of tumour stage, size and grade, with a 
concomitant decrease in survival [12]. Furthermore, using 
a proteomic approach [13], and more recently by combining 
proteomics and metabolomics analysis [9], it has been 
revealed that grade-dependent metabolic reprogramming 
occurs in ccRCC tissues, with the Warburg effect relatively 
more prominent in higher grade tumors at the expense of 
the TCA cycle and oxidative metabolism. Grade-dependent 
alterations were also shown in fatty acid, glutamine and 
glutathione metabolisms [9]. Even if different targeted 
therapeutics interfering with various aspects of RCC 
metabolism are currently in clinical development [14], at 
present there is no grade-specific therapy addressing this 
metabolic reprogramming.
To further characterize such grade-dependent 
reprogramming, in anticipation of rationally developing 
novel grade-specific metabolic targeted approaches, an 
in vitro model more representative of the ccRCC tissue with 
respect to the immortalized cell lines, and that maintains 
grade-dependent tissue metabolic features, would be useful. 
From ccRCC tissue samples we established primary cell 
cultures that at the early passages retain the phenotypic, 
genomic, transcriptomic and proteomic profile of the 
corresponding tissues, and therefore share many biological 
processes known to be important for ccRCC development 
and progression [15–18].
Here we aim to investigate how the specific 
inhibition of glycolysis or fatty acid oxidation affect the 
reduced pyridine nucleotide level and energy state and 
consequently the viability and proliferation of low- and 
high-grade ccRCC cells. The primary cell cultures from 
ccRCC of low- and high-grade, which retain the metabolic 
phenotype of the corresponding tissues, were essential for 
these purposes.
RESULTS
The “clear cell” morphology of ccRCC tissues 
due to neutral lipid and glycogen storage is 
maintained in primary cell cultures 
Hematoxylin/Eosin (HE) staining showed that 
ccRCC primary cell cultures maintained the typical 
vacuoles responsible for the “clear cell” morphology 
of corresponding ccRCC tissue. The “clear” vacuoles 
contained neutral lipids and glycogen, as proved by Oil 
Red O (ORO) and Periodic Acid-Schiff (PAS) staining 
respectively, in both ccRCC tissues and primary cell 
cultures (Figure 1).
Metabolic gene expression profile of ccRCC 
primary cultures
To highlight the metabolic signature of ccRCC 
primary cultures we revised our previously published 
gene expression microarray data, generated on a collection 
of ccRCC and normal cortex primary cultures, and 
corresponding Gene Ontology (GO) enrichment analysis 
[17] to focus on metabolic processes. In ccRCC primary 
cultures, we found a significant enrichment for 35 GO-
biological process (BP) terms related to several classes of 
metabolic processes (Figure 2). The same GO enrichment 
analysis performed on publicly available ccRCC tissue 
transcriptomic data generated by RNAseq technology 
[19] evidenced that these 35 metabolic processes were also 
shared by tumor tissues (Figure 2). In particular, among 
them we found 12 GO-BP terms specifically related to 
carbohydrate and lipid metabolism. These metabolic 
processes were reported as characteristics of ccRCC 
biology even in other transcriptomic analyses performed 
on tissues [20].
These findings indicate that ccRCC primary cultures 
retained, on the whole, the metabolic gene profiling of 
tumor tissues, in particular the gene profiling of glucose 
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Figure 1: ccRCC primary cell cultures maintain the lipid and glycogen storage of tissues. Representative images of normal 
cortex and ccRCC tissue sections and primary cell cultures after Haematoxylin/Eosin (HE), Oil Red O (ORO) and Periodic Acid-Schiff 
(PAS) staining captured at original magnification of 200× (scale bar: 100 μm) and 400× (scale bar: 50 μm).
Figure 2: Enrichment for GO biological processes related to metabolism in ccRCC primary cultures and tissues. The 35 
significant metabolic GO-BP terms shared between cultures (black bars) and tissues (white bars) are represented. The -log P value (−logP) 
represents the significance level. The twelve GO-BP terms specifically related to carbohydrate and lipid metabolism are indicated in bold.
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and lipid metabolism, supporting the use of these cultures 
for accurate metabolic functional studies.
Lactate fermentation is upregulated in ccRCC 
primary cell cultures
To further improve the metabolic characterization of 
our cultures, we measured lactate dehydrogenase A (LDHA) 
expression and L-lactate production as probes for aerobic 
glycolysis/lactate fermentation. An increment of LDHA 
protein level, the enzyme involved in converting pyruvate 
to lactate, and both intracellular and secreted L-lactate was 
observed in our ccRCC cultures as compared with normal 
cortex cultures (Figure 3A and 3B). These data confirm that 
the aerobic glycolysis/lactate fermentation was upregulated 
in our ccRCC primary cell cultures, in agreement with the 
behavior of ccRCC tissues [9].
The storage of neutral lipids and glycogen and 
the production of lactate are grade-dependent in 
ccRCC primary cell cultures
Morphological evaluation of the lipid and glycogen 
storages in ccRCC primary cell cultures and corresponding 
tissues stratified on the basis of Fuhrman low-grade (G1–G2) 
and high-grade (G3–G4), showed a decrease of ORO-stained 
lipid droplets and PAS-stained glycogen content in higher 
grade ccRCC primary cultures and in the corresponding 
tissue samples (Figure 4A). These observations were 
quantitatively confirmed by the evaluation of intracellular 
glycogen content in tissue samples and primary cell cultures 
(Figure 4B and 4D) and of ORO stained area in tissue slides 
(Figure 4C). The grade-dependent decrease of lipid storage 
was also quantitatively confirmed in primary cell cultures 
by analyzing the expression of PLIN2, the lipid droplet 
coat protein of non-adipose tissues described as a marker of 
intracellular neutral lipid storage [21]. PLIN2 transcript and 
protein expression was significantly lower in normal cortex 
with respect to ccRCC primary cell cultures (Figure 4E 
and 4F), and notably PLIN2 protein level was lower in high-
grade compared to low-grade ccRCC cells.
Moreover, to evaluate whether in ccRCC cultures 
aerobic glycolysis/lactate fermentation was also grade-
dependent, we assayed LDHA protein expression and 
lactate secretion of low-grade and high-grade ccRCC 
primary cultures. Western blot analysis showed that LDHA 
protein level was increased in all grade ccRCC cultures 
as compared with normal cortex cells (Figure 4G), but 
L-lactate was significantly more abundant in culture media 
of high-grade with respect to low-grade ccRCC cells 
(Figure 4H). This discrepancy between LDHA expression 
and lactate secretion may be due to the fact that the activity 
of an enzyme may change even without an alteration of its 
protein concentration, as also previously noted [9]. These 
Figure 3: Lactate production is upregulated in ccRCC primary cell cultures. (A) Representative western blot of normal 
cortex (n = 2) and ccRCC (n = 3) primary cell culture, showing LDHA and β-actin proteins. In the graph, the normalized LDHA band 
intensities of normal cortex (n = 7) and ccRCC (n = 19) primary cell cultures are shown. (B) Lactate quantification performed in cell lysates 
(cells) and conditioned culture medium (media) of normal cortex (n = 6) and  ccRCC (n = 7) primary cultures. Lactate concentration values 
were normalized to cell protein concentration. Data expressed as mean ± SEM; *p < 0.05. 
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data indicate that aerobic glycolysis/lactate fermentation 
was upregulated in our high-grade ccRCC primary cell 
cultures as described in high-grade ccRCC tissues [9].
2DG treatment decreases the lactate, ATP and 
reduced MTT dye level in ccRCC cultures of 
high-grade but the ATP level only in those of 
low-grade
To study whether glucose metabolism contributed to 
reduced pyridine nucleotide level and energy state of low- 
and high-grade ccRCC cells, we treated primary cultures 
with 5 mM 2-Deoxy-D-glucose (2DG). 2DG is known to be 
phosphorylated by hexokinase in the first step of glycolysis 
resulting in a non-hydrolysable substrate which accumulates 
in the cells and leads to inhibition of both glycolysis and 
pentose phosphate pathway [22]. After 24 hours of treatment 
the residual glucose level in the medium of normal cortex 
and ccRCC cultures was significantly higher than in 
corresponding control medium (Figure 5A) proving that 
5 mM 2DG efficiently inhibited the first step of glycolytic 
pathway. As expected, the 2DG treatment did not induce 
a decrease of lactate secretion into the medium of normal 
cortex cultures (Figure 5B), supporting the notion that 
normal cells do not preferentially use lactate fermentation 
to metabolize glucose. Even in low-grade ccRCC cells 2DG 
did not decrease lactate production. Instead, 2DG treatment 
significantly decreased lactate secretion in high-grade cells 
(Figure 5B), confirming that the aerobic glycolysis/lactate 
fermentation is up-regulated in high-grade ccRCC primary 
cultures, as shown in Figure 4H.
Moreover, treatment with 5 mM 2DG for 72 hours 
significantly affected the capability of normal cortex 
and high-grade but not low-grade ccRCC cells to 
chemically reduce the 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium (MTT) dye (Figure 5C). The 
bioreduction of MTT dye is a NAD(P)H-dependent process 
[23] and thus it can be used as probe for evaluating the 
changes in reduced pyridine nucleotide level (NADH and 
to a lesser extent NADPH) [24].
Twenty-four hours of 2DG treatment also significantly 
affected ATP level in normal cortex and both high- and low-
grade ccRCC cells (Figure 5D). Thus, the treatment with 
2DG induced a concomitant decrease of lactate, NAD(P)H 
and ATP level only in high-grade ccRCC cells, and these data 
highlight that glucose metabolism driven through aerobic 
glycolysis mainly contributed to reduced pyridine nucleotide 
level and energy state of these cells.
Etomoxir treatment decreases the ATP level in 
ccRCC cultures of high-grade and the reduced 
MTT dye level in those of low- grade
To evaluate whether lipid metabolism contributed 
to reduced pyridine nucleotide level and energy state 
of low-grade and high-grade ccRCC cells, we treated 
primary cultures with Etomoxir known to inhibit the 
mitochondrial fatty acid transporter Carnitine palmitoyl 
transferase 1 (CPT1), responsible for synthesis and import 
of fatty acylcarnitines across the outer mitochondrial 
membrane. The reaction catalysed by CPT1 is considered 
the rate-limiting step of fatty acid β-oxidation [25]. It has 
been previously shown [9] that the treatment with 50 µM 
Etomoxir for 72 hours induced an increase of lipid storage 
in both normal cortex and ccRCC primary cultures, 
proving that this drug concentration efficiently inhibited 
CPT1 in our cells. Here we show that the treatment with 
50 µM Etomoxir also significantly affected the capability 
of normal cortex and low-grade but not high-grade ccRCC 
cells to bioreduce MTT dye (Figure 6A), whereas 24 hours 
of Etomoxir treatment affected ATP level in normal 
cortex and high-grade but not in low-grade ccRCC cells 
(Figure 6B). These data highlight that the inhibition of fatty 
acid oxidation affected only the reduced pyridine nucleotide 
level in low-grade and only the energy state in high-grade 
ccRCC cells, suggesting a different grade-dependent 
metabolic function of β oxidation process in ccRCC.
Cell proliferation and viability is affected by 
2DG in low-grade ccRCC cultures and by 
Etomoxir in those of high-grade
To evaluate whether the inhibition of glycolysis or 
fatty acid oxidation might have a cytostatic effect in our 
ccRCC cultures, we quantified the cells positive for the 
proliferation marker Ki67 after 72 hours of treatment with 
2DG or Etomoxir. Both treatments significantly decreased 
cell proliferation in normal cortex and in low- and high-
grade ccRCC cultures (Figures 7A and 7B).
Instead, the cell viability, evaluated by FACS after 
Annexin V/IP staining, was differently affected based 
on the metabolic treatment. 2DG induced a significant 
decrease of cell viability in normal cortex and low-grade 
ccRCC cultures (Figure 7C). In normal cortex cultures the 
viability dropped to 47% and the apoptotic cells raised 
from about 12% to 51%, in low-grade ccRCC cultures 
the viable cells decreased to 79% and the apoptotic cells 
raised from 15% to 19%. Etomoxir induced a significant 
decrease of viable cells in high-grade ccRCC cultures 
only, the viable cells decreased to 68% and the dead cells 
significantly raised from 19% to 23%. It is noteworthy 
that the inhibition of fatty acid oxidation did not affect 
the viability and just slightly the proliferation of normal 
cortex cells, whereas the inhibition of glycolysis severely 
affected both their viability and proliferation.
These data evidence that a cytostatic and cytotoxic 
effect can be obtained by inhibition of glycolysis in 
low-grade ccRCC cells and by inhibition of fatty acid 
oxidation in high-grade ccRCC cells. The extension of 
treatment until five days did not quantitatively increase 
the difference in viability between control and treated cells 
(data not shown).
Oncotarget6www.impactjournals.com/oncotarget
Figure 4: Neutral lipid and glycogen storage is decreased and lactate production increased in high-grade ccRCC 
primary cultures. (A) Representative images of low-grade and high-grade ccRCC tissue sections and matched primary cell cultures 
after Oil Red O (ORO) and Periodic Acid-Schiff (PAS) staining captured at original magnification of 200× (scale bar: 100 μm). 
(B) Glycogen quantification performed in normal cortex (n = 4), low-grade (n = 7) and high-grade (n = 8) ccRCC tissue samples. (C) 
Neutral lipid quantification in ORO stained slides of normal cortex (n = 3), low-grade (n = 7) and high-grade (n = 8) ccRCC tissue samples. 
ORO area was quantified in three to six fields per slides and expressed as percentage of total area analyzed. (D) Glycogen quantification 
performed in normal cortex (n = 3), low-grade (n = 4) and high-grade (n = 3) ccRCC primary cultures. (E) Real-time PCR analysis of 
PLIN2 expression performed in normal cortex (n = 15), low-grade (n = 11) and high-grade (n = 9) ccRCC primary cultures. Box and 
whiskers plot corresponds to 1–99th percentiles (bars), 25–75th percentiles (box), and median (line in box). (F) Representative western blot 
of three different normal cortex, low-grade and high-grade ccRCC primary cell cultures showing the PLIN2 and β-actin proteins. The graph 
shows the normalized PLIN2 band intensities of normal cortex (n = 8), low-grade (n = 8) and high-grade (n = 7) ccRCC primary cultures. 
To evidence the difference between normal cortex and all ccRCC cultures, in B-F panels the average of low and high-grade ccRCC data 
is also reported. (G) Representative western blot of three different normal cortex, low-grade and high-grade ccRCC primary cell cultures 
showing the LDHA and β-actin proteins. The graph shows the normalized LDHA band intensities of normal cortex (n = 7), low-grade 
(n = 11) and high-grade (n = 8) ccRCC primary cultures. (H) Lactate quantification performed in conditioned culture medium of normal 
cortex (n = 5), low- grade (n = 4) and high-grade (n = 3) ccRCC primary cultures. Data expressed as mean ± SEM; *p < 0.05.
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DISCUSSION
In this study we showed that ccRCC primary cell 
cultures maintained in early passages the cytological, 
transcriptomic and metabolic features of the original tumor 
tissues, confirming the up-regulation of aerobic glycolysis/
lactate fermentation. Our primary cultures also showed a 
grade-dependent modulation of lipid and glycogen storage 
and aerobic glycolysis/lactate fermentation, accordingly to 
the grade-dependent metabolic reprogramming described 
in ccRCC tissues [9], and highlighted their suitability as 
ccRCC in vitro model for metabolic studies. The metabolic 
treatments of these ccRCC primary cell cultures induced 
interesting modifications in their energy state, reduced 
pyridine nucleotide level, cell proliferation and viability.
The treatment with 2DG significantly affected the 
capability of high-grade ccRCC cells, but not low-grade, 
to chemically reduce the MTT dye. MTT assay was here 
Figure 5: Metabolic effect of 2DG treatment in low- and high-grade ccRCC and normal cortex primary cultures. 
(A) Glucose quantification performed in conditioned culture medium of normal cortex (n = 3), low- grade (n = 4) and high-grade (n = 3) 
ccRCC primary cultures treated for 24 hours with 5 mM 2DG. (B) Lactate quantification performed in conditioned culture medium of normal 
cortex (n = 4), low-grade (n = 3) and high-grade (n = 3) ccRCC primary cultures treated for 24 hours with 5 mM 2DG. (C) Quantification of 
reduced MTT dye performed by MTT assay in normal cortex (n = 4), low-grade (n = 9) and high-grade (n = 5) ccRCC cultures treated for 72 
hours with 5 mM 2DG. (D) Quantification of ATP content in normal cortex (n = 3), low-grade (n = 5) and high- grade (n = 4) ccRCC cultures 
treated for 24 hours with 5mM 2DG. All data are represented as percentage with respect to corresponding control (untreated) cells considered 
equal to 100%, except for panel A in which the treated cells are considered equal to 100%. Data expressed as mean ± SEM; *p < 0.05.
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used as probe for the evaluation of changes in cellular 
reduced pyridine nucleotide level, NADH and to a lesser 
extent NADPH [23–24], to which the mitochondrial TCA 
and β-oxidation pathways, but also glycolysis and the 
pentose phosphate pathway, contribute. In 2DG treated 
high-grade ccRCC cells the decrease of reduced MTT dye 
level, associated with the decrease of lactate secretion, 
suggests involvement of glucose metabolism driven through 
the aerobic glycolysis/lactate fermentation pathway in 
NAD(P)H production. In fact, in high-grade cells fatty acid 
oxidation did not appear relevant for NAD(P)H production 
because Etomoxir treatment did not significantly affect 
the cell capability to reduce MTT dye. Thus, in our high-
grade ccRCC cultures the glucose metabolic pathway had a 
peculiar role in NAD(P)H production, although not fuelled 
by the poor glycogen storage.
In low-grade ccRCC cells the poor production of 
lactate in spite of glucose consumption, and the unchanged 
lactate secretion after 2DG treatment, demonstrated that 
glucose underwent mitochondrial catabolism in these 
cells. Otherwise, in our low-grade ccRCC cells the use 
of mitochondrial metabolism was also evidenced by 
the significant decrease of reduced MTT dye after the 
treatment with Etomoxir that inhibits mitochondrial fatty 
acid metabolism. However, the fact that MTT data did not 
change after treatment of these cells with 2DG suggested 
that the mitochondrial metabolism of glucose contributed 
only marginally to the NAD(P)H production in low grade 
ccRCC cells.
2DG treatment in low-grade ccRCC cells 
significantly affected ATP production that instead was 
not affected by the inhibition of fatty acid oxidation with 
Etomoxir. This result together with the unchanged lactate 
secretion after 2DG treatment highlighted the importance 
of the mitochondrial metabolism of glucose for energy 
production that in these low-grade cells might be also 
fuelled by the large glycogen storage. In high-grade 
ccRCC cells ATP production was significantly affected 
Figure 6: Metabolic effect of Etomoxir treatment in low- and high-grade ccRCC and normal cortex primary cultures. 
(A) Quantification of reduced MTT dye performed by MTT assay in normal cortex (n = 10), low-grade (n = 11) and high-grade (n = 13) 
ccRCC cultures treated for 72 hours with 50 µM Etomoxir. (B) Quantification of ATP content in normal cortex (n = 3), low-grade (n = 4) 
and high-grade (n = 4) ccRCC cultures treated for 24 hours with 50 µM Etomoxir. Data, expressed as mean ± SEM, are represented as 
percentage with respect to corresponding control (untreated) cells; *p < 0.05.
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by Etomoxir, other than 2DG, suggesting that these cells 
relied mainly on fatty acid oxidation, other than on aerobic 
glycolysis/lactate fermentation, for ATP production. In 
fact, the decrease of ATP in high-grade cells, in presence 
of 2DG, evidenced that the poor glycogen storage was not 
enough for efficiently fuelling the aerobic glycolysis that 
resulted to be inadequate to sustain alone the energy balance 
in these cells. As expected, the treatment with 2-DG did 
not affect lactate production in normal cortex cultures but, 
like Etomoxir, induced a decrease of reduced MTT dye and 
ATP level. This result confirmed the well-known relevant 
role that both glucose and lipid metabolism have in normal 
cells for NAD(P)H production and ATP synthesis, through 
mitochondrial oxidative phosphorylation.
In our in vitro model the inhibition of glycolysis 
with 2DG affected the viability of normal cortex and low-
grade ccRCC cells. Conversely, the inhibition of fatty acid 
oxidation by Etomoxir induced a significant decrease of 
Figure 7: Cell proliferation and viability of low- and high-grade ccRCC and normal cortex primary cultures treated 
with 2DG or Etomoxir. (A–B) Quantification of cellular proliferation evaluated as Ki67 positive cells after immunofluorescence 
staining in  normal cortex (n = 3), low-grade (n = 4) and  high-grade (n = 5) ccRCC cultures treated for 72 hours with 5 μM 2DG (A) 
or 50 μM Etomoxir (B). Data, obtained in at least five 400x micrographs per sample, were represented as percentage with respect to 
corresponding control (untreated) samples; *p < 0.05. (C–D) Representative images of FACS analysis of cell viability evaluated with 
Annexin V/propidium iodide in normal cortex (n = 4), low-grade (n = 4) and  high-grade (n = 5) ccRCC cultures treated for 72 hours with 
5mM 2DG (C) or 50 μM Etomoxir (D). Percentages of viable cells (bottom left quadrant of each plot) are indicated; *p < 0.05, paired 
Student’s t-test. Data are expressed as mean ± SEM. 
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viable cells in high-grade ccRCC cultures only, without 
affecting cortex cell viability. These cytotoxic effects 
might be due to the significant decrease of ATP production 
mainly obtained by fatty acid oxidation in high-grade 
ccRCC cells and by mitochondrial glucose metabolism in 
low-grade cells.
Even the decreased cell proliferation observed after 
2DG or Etomoxir treatment might be due to the decrement 
of ATP. In particular, the cytostatic effect of Etomoxir agrees 
with data showing a cell cycle arrest in Caki-1 and 786-O 
ccRCC cell lines treated with Peroxisome proliferator-
activated receptor a (PPARa) antagonists [26] that, 
downregulating the PPARa target CPT1 [27], might in part 
reproduce the metabolic and functional effects of Etomoxir. 
In low-grade ccRCC cells the cytostatic effect of Etomoxir 
seems to correlate with the observed decrease of the 
NAD(P)H-dependent MTT dye reduction. In cancer 
cells it is well known that fatty acid oxidation is relevant, 
through metabolic pathways fuelled by cytosolic citrate, 
to the production of NADPH involved in the synthesis of 
membrane fatty acids during cell proliferation [28]. The 
decrease of reduced MTT dye level, observed in 2DG treated 
high-grade ccRCC cells, might in part justify, through the 
same mechanism, the cytostatic effect in these cells.
Therefore, our data evidenced that in high-grade 
ccRCC cells fatty acid oxidation mainly, but also aerobic 
glycolysis, are important for energy production, whereas 
glucose metabolism uniquely contributes to the reduced 
pyridine nucleotide level. Instead, in low-grade ccRCC 
cells the fatty acid oxidation appeared to control the 
reduced pyridine nucleotide level, while the mitochondrial 
glucose metabolism controlled the cell energy state.
It is of note that the prevalent aerobic glycolysis 
(Warburg effect) and the active β-oxidation of our 
high-grade ccRCC cells have a strict link with the 
nuclear morphological features of high-grade Fuhrman 
classification, which are characteristic of cycling or 
immature cells [29] and correlate with the more aggressive 
behavior of high-grade ccRCC tumor that has the worst 
prognosis [5]. The Fuhrman grade and the cell proliferation/
cycling characteristics correlate even in our primary cell 
cultures in which a larger percentage of Ki-67 positive 
cells was measured in high-grade with respect to low-
grade ccRCC cultures (33% versus 18%). In addition, 
the metabolic characteristics of our high-grade ccRCC 
cells justify the described higher 18F-fluorodeoxyglucose 
uptake of high-grade ccRCC [30] with respect to the low-
grade tumors that likely relay on a prevalent oxidative 
mitochondrial metabolism as the normal cortex cells.
Our findings indicate that the Warburg effect is not a 
common feature shared by all ccRCC, and the β-oxidation 
can be activated for different metabolic needs in ccRCC 
of different grade. Our data also support the current 
trend that underline the importance of the classification 
of malignancies even on the basis of metabolic pathway 
alterations [31]. This trend will promote the use of 
metabolism reprogramming to open novel opportunities 
for new diagnostic and therapeutic options [32]. The 
cytotoxic effect that we observed exclusively in high-
grade ccRCC cells and not in normal cortex cells after the 
inhibition of fatty acid oxidation, can be a strong incentive 
to attempt a metabolic grade-dependent therapeutic 
approach, not investigated yet in ccRCC [14].
MATERIALS AND METHODS
Tissues
Tumor (n = 56) and normal kidney (n = 36) tissues 
were obtained from 56 patients following nephrectomy 
due to the presence of ccRCC. The tissues collected were 
those exceeding the diagnostic needs. The normal cortex 
was taken from a healthy region of the kidney, without any 
indication of cancer. All procedures were performed after 
written consent and were approved by the Local Ethical 
Committee.
The clinico-pathological characteristics of enrolled 
ccRCC patients, reported in Table 1, also included the 
pathological stage and Fuhrman grade, according to 2004 
World Health Organization classification.
Primary cell cultures
Primary cell cultures were obtained from normal 
cortex and tumor tissues, the culture conditions and 
immunophenotypic characterization were performed as 
described [15]. The primary cell cultures were used at the 
first confluence.
Tissue and primary cell culture staining
HE and PAS staining were conducted on formalin 
fixed and paraffin-embedded tissue sections, following 
standard protocols [33], and on first-confluent primary 
cell cultures grown on glass coverslips and fixed in 10% 
formalin for 1 hour. ORO staining was performed on 
cryostat tissue sections and on formalin fixed cultures, 
as described [9]. The stained samples were analyzed by 
Nikon Eclipse E800 microscope with 10×, 20× and 40× 
objectives (Nikon Instruments spa, Firenze, Italy). Three/
four pictures for each slide were randomly captured and 
analyzed by LuciaG Image analysis system (Nikon). Lipid 
storage quantification was obtained by analysis, with 
ImageJ software (NIH, Bethesda, MD), of ORO stained 
tissue pictures captured at 100× magnification.
Gene expression microarray profiling
ccRCC and normal cortex primary cultures were 
characterized for transcriptome profile by microarray 
technology on Affymetrix GeneChip Human Exon 1.0 
ST Arrays (Affymetrix, Santa Clara, CA, USA), as 
we previously described [17]. CEL files are available 
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at Array Express repository under accession number 
E-MTAB-4074 (http://www.ebi.ac.uk/arrayexpress/
experiments/E-MTAB-4074/). The differentially expressed 
genes (DEGs) between ccRCC and cortex cultures were 
calculated using Partek Genomic Suite software (Partek 
Inc., St. Louis, MO) by ANOVA method. Gene Ontology 
biological processes (GO-BP) significantly enriched in 
our ccRCC cultures were identified by ToppGene suite 
(https://toppgene.cchmc.org/). ToppCluster tool (https://
toppcluster.cchmc.org/) was used to compare the GO-
BP enriched in our ccRCC cultures to those enriched 
in ccRCC tissues obtained from the RNA-seq DEG list 
reported by Wozniak et al. [19]. 
RNA extraction and real-time PCR
Total RNA extraction and reverse transcription 
(RT) were carried out as previously described [34]. Real-
time PCR was performed with TaqMan Gene Expression 
Assay kits for PLIN2 transcript (Hs 00605340_m1) 
and for GAPDH (Hs99998805_m1 kit) according to 
manufacturer’s instructions (Applied Biosystems, Foster 
City, CA). The amplifications were carried out in 20 μl 
reactions containing 100 ng of cDNA, 1X Universal PCR 
Master Mix, and corresponding primers and probes, in 
duplicate for each sample on an ABI PRISM® 7900HT 
Fast Real-Time PCR System (Applied Byosystems). 
PLIN2 transcript levels were represented as relative 
expression (2−∆∆CT) with respect to normal cortex samples.
Protein extraction and western blot analysis
Thirty μg of protein lysates obtained from first-
confluent primary cell cultures, quantified with BCA 
microassay (Sigma Aldrich, St. Louis, MO) and separated 
on NuPage 4 to 12% Bis-Tris pre-cast gels (Thermo 
Fisher, Waltham, MA) [35], were submitted to western 
blotting [36] with mouse monoclonal antibody against 
PLIN2 (dilution 1:500; AP125, Progen, Heidelberg, 
Germany), or rabbit polyclonal antibody against LDHA 
(dilution 1:1000; Cell Signaling, Boston, MA), or against 
β-actin (dilution 1:1000; Sigma-Aldrich). Densitometric 
analysis of specific bands was performed by ImageJ 
software, and the specific band intensities were normalized 
with corresponding β-actin for quantification.
Glycogen quantification
Intracellular glycogen content was quantified in 
tissue homogenates and first-confluent primary cell culture 
lysates using a Glycogen Assay kit (Biovision, Milpitas, 
CA) following the manufacturer’s instructions. Data were 
expressed as μg per μg of total protein content.
Metabolic treatments
An equal number of normal cortex and ccRCC cells 
from first-confluent primary cultures were plated and 
grown for 24 hours in culture medium (complete DMEM 
Table 1: Clinicopathological variables of 56 ccRCC cases analyzed in the study
Variable n (%)
Age (years)
    median 71
    range 41–86
Gender
    male 37 (66.1)
    female 19 (33.9)
Tumor size (cm)
    median 4.5
    range 2–10
Pathological stage
    pT1a 13 (23.2)
    pT1b 12 (21.4)
    pT2 10 (17.9)
    pT3a 21 (37.5)
    pN+ 1 (1.8)
    cM+ 3 (5.4)
Fuhrman grade
G1–2 32 (57.1)
G3–4 24 (42.9)
Oncotarget12www.impactjournals.com/oncotarget
medium containing 5 mM glucose). The cells were then 
washed with PBS and incubated for 24 or 72 hours in 
culture medium with 5 mM 2-Deoxy-D-glucose 2DG, or 
50 µM Etomoxir (Sigma-Aldrich).
Lactate quantification
Untreated first-confluent  cells were lysed in 50 μl 
H2O and centrifuged to remove the insoluble debris. 
Twenty μl of the cellular soluble fraction lysate, and of 
conditioned culture medium of untreated or 24 hour 2DG 
treated cells, were respectively diluted in 1 ml pre-filled 
reaction cup containing Glucose/Lactate hemolyzing 
solution (Biosen, EFK diagnostics, Cardiff, England) 
and assayed for L-lactate content by a lactate analyzer 
(BiosenC-Line, EKF diagnostics). Concentration values 
were normalized for viable cell count or, when indicated, 
for cell protein concentration.
Glucose quantification
Five hundred μl of conditioned medium of untreated 
or 24 hour 2DG treated cells were collected, spinned 
for 5 min to eliminate floating cells and debris, and 
assayed for glucose content using Roche COBAS 8000 
analyzer (Roche diagnostics spa, Monza, Italy). Values 
were normalized for viable cell count and expressed as 
percentage with respect to 2DG treated cells.
MTT assay
Quantification of the NAD(P)H-dependent 
capability of cells to reduce MTT dye in presence or 
absence of metabolic treatment was measured by MTT 
assay (Sigma-Aldrich) [37]. Briefly, 1 × 104 cells were 
plated in 96-well plates, and after 72 hour of 2DG or 
Etomoxir treatment the cells were incubated in MTT 
solution. After 3 hours, the MTT solution was removed, 
and the blue crystalline precipitate in each well was 
dissolved in DMSO. Absorbance of each well at 570 nm 
was quantified using the microplate reader Victor Wolla 
C1420 (Perkin Elmer, Woltham, MA) and expressed as 
percentage with respect to untreated cells.
ATP quantification
Quantification of cellular ATP content in presence 
or absence of metabolic treatment was measured 
using ATP Bioluminescence Assay Kit CLS II (Roche 
Diagnostics, Mannheim Germany). 1.5 × 105 cells were 
plated in 12-well plates and treated for 24 hours with 
2DG or Etomoxir. ATP content was quantified using the 
microplate luminometer Victor Wolla C1420 (Perkin 
Elmer) according to manufacturer’s instructions. Data 
normalized for cell protein concentration were expressed 
as percentage with respect to untreated cells.
Ki67 immunofluorescence staining
To assess the effect of metabolic treatments on 
cell proliferation of ccRCC and normal cortex primary 
cultures 1 × 105 cells seeded onto coverslips were treated 
with 2DG or Etomoxir for 72 hours. Immunofluorescence 
staining was performed using mouse monoclonal antibody 
against Ki67 (1:75 dilution; Clone MIB-1; DAKO, 
Glostrup, Denmark) and Alexa Fluor 488 goat anti-
mouse polyclonal secondary antibody (1:100 dilution; 
Molecular Probes, Carlsberg, CA) as previously described 
[15]. Nuclei were counterstained with DAPI. For each 
treatment, Ki67 positive nuclei were quantified in at least 
five immunofluorescence micrographs, obtained at 400x 
magnification using a Zeiss LSM710 confocal microscope 
and Zen2009 software (Zeiss, Oberkochen, Germany), 
and normalized by total nuclei. Normalized Ki67 positive 
cells in treated samples were expressed as percentage of 
corresponding untreated samples. 
Cell viability assay
Cell viability of metabolically treated ccRCC and 
normal cortex primary cultures was assessed. 2.5 × 105 
cells were seeded in 6-well plates and treated with 2DG or 
Etomoxir for 72 hours. Cell viability was evaluated with 
FITC Annexin V Apoptosis detection kit and Propidium 
Iodide (PI) (Biolegend, San Diego, CA) according to the 
manufacturer’s instructions. Briefly, after two washes 
with cold PBS, the cells were resuspended in 100 µl of 
Annexin V Binding Buffer. The cell solution was then 
incubated with 5 µl of FITC Annexin V and 10 µl of PI 
for 15 minutes at room temperature in the dark. After the 
incubation, 200 µl of Annexin V Binding Buffer were 
added. FACS analysis was performed on 10000 events 
with MoFlo Astrios Cell Sorter and Kaluza software 
(Beckman Coulter srl, Milano, Italy). Viable (Annexin 
V and PI negative), dead (PI positive) and apoptotic 
(Annexin V positive) cells in treated and untreated samples 
were expressed as percentage with respect to total number 
of analysed events.
Statistical analysis
Data were analysed using unpaired Student’s t-test 
or, where indicated, by paired Student’s t-test. The results 
were expressed as mean ± SEM. P-values < 0.05 were 
considered as statistically significant.
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